CVS 2013 Annual Report Download - page 75

73
2013 Annual Report
On December 2, 2013, the Company issued $750 million of 1.2% unsecured senior notes due December 5, 2016;
$1.25 billion of 2.25% unsecured senior notes due December 5, 2018; $1.25 billion of 4.0% unsecured senior notes
due December 5, 2023; and $750 million of 5.3% unsecured senior notes due December 5, 2043 (the “2013 Notes”)
for total proceeds of approximately $4.0 billion, net of discounts and underwriting fees. The 2013 Notes pay interest
semi-annually and may be redeemed, in whole at any time, or in part from time to time, at the Company’s option at
a defined redemption price plus accrued and unpaid interest to the redemption date. The net proceeds of the 2013
Notes were used to repay commercial paper outstanding at the time of issuance and to fund the acquisition of
Coram LLC in January 2014 (See Note 15). The remainder will be used for general corporate purposes.
On November 26, 2012, the Company issued $1.25 billion of 2.75% unsecured senior notes due December 1, 2022
(the “2012 Notes”) for total proceeds of approximately $1.24 billion, net of discounts and underwriting fees. The 2012
Notes pay interest semi-annually and may be redeemed, in whole at any time, or in part from time to time, at the
Company’s option at a defined redemption price plus accrued and unpaid interest to the redemption date. The net
proceeds of the 2012 Notes were used for general corporate purposes and to repay certain corporate debt.
On November 26, 2012, the Company announced tender offers for any and all of the 6.6% Senior Notes due 2019,
and up to a maximum amount of the 6.125% Senior Notes due 2016 and 5.75% Senior Notes due 2017, for up to
an aggregate principal amount of $1.0 billion. In December 2012, the Company increased the aggregate principal
amount of the tender offers to $1.325 billion and completed the repurchase for the maximum amount. The Company
paid a premium of $332 million in excess of the debt principal in connection with the tender offers, wrote off $13 mil-
lion of unamortized deferred financing costs and incurred $3 million in fees, for a total loss on the early extinguishment
of debt of $348 million. The loss was recorded in income from continuing operations on the consolidated statement
of income.
In connection with the Company’s acquisition of the UAM Medicare Part D Business in April 2011, the Company
assumed $110 million of long-term debt in the form of Trust Preferred Securities that mature through 2037. During the
years ended December 31, 2012 and 2011, the Company repaid $50 million and $60 million, respectively, of the Trust
Preferred Securities at par.
On May 12, 2011, the Company issued $550 million of 4.125% unsecured senior notes due May 15, 2021 and issued
$950 million of 5.75% unsecured senior notes due May 15, 2041 (collectively, the “2011 Notes”) for total proceeds
of approximately $1.5 billion, net of discounts and underwriting fees. The 2011 Notes pay interest semi-annually and
may be redeemed, in whole at any time, or in part from time to time, at the Company’s option at a defined redemption
price plus accrued and unpaid interest to the redemption date. The net proceeds of the 2011 Notes were used to
repay commercial paper borrowings and certain other corporate debt, and were used for general corporate purposes.
In December 2011 and July 2012, the Company repurchased $958 million and $1 million of the principal amount of
its ECAPS at par. The fees and write-off of deferred issuance costs associated with the early extinguishment of the
ECAPS were de minimis . The remaining $41 million of outstanding ECAPS at December 31, 2013 are due in 2062.
The ECAPS pay interest semi-annually and may be redeemed at any time, in whole or in part at a defined redemption
price plus accrued interest.
The credit facilities, back-up credit facilities, unsecured senior notes and ECAPS contain customary restrictive financial
and operating covenants. The covenants do not materially affect the Company’s financial or operating flexibility.
The aggregate maturities of long-term debt for each of the five years subsequent to December 31, 2013 are $561 million
in 2014, $576 million in 2015, $1.2 billion in 2016, $1.3 billion in 2017 and $1.3 billion in 2018.